Dgdc Diet And Cure Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.05 Cr
- Revenue Growth -2.49%
- Profit Growth 25.88%
- Ebitda 65.67%
- Net Worth 36.65%
- Total Assets 29.94%
About Dgdc Diet And Cure
Dgdc Diet And Cure Private Limited (DDACPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2018 (Six years and ten months 4 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.05 Cr.
Sachin Gandhi and Divya Gulati serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85320DL2018PTC332740
- Company No.
332740
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dgdc Diet And Cure?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Gandhi  | Director | 18-Apr-2018 | Current |
| Divya Gulati | Director | 18-Apr-2018 | Current |
Financial Performance of Dgdc Diet And Cure.
Dgdc Diet And Cure Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.49% decrease. The company also saw a substantial improvement in profitability, with a 25.88% increase in profit. The company's net worth Soared by an impressive increase of 36.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dgdc Diet And Cure?
In 2021, Dgdc Diet And Cure had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dgdc Diet And Cure Consultancy Private LimitedSachin Gandhi and Divya Gulati are mutual person
Charges (Loans)
₹10.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2023 | Others | ₹1.05 Cr | Open |
How Many Employees Work at Dgdc Diet And Cure?
Unlock and access historical data on people associated with Dgdc Diet And Cure, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dgdc Diet And Cure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dgdc Diet And Cure's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.